Annual bonuses for senior executives will vary widely,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Annual bonuses for senior executives will vary widely, Willis Towers Watson poll finds

ARLINGTON, Va., Dec. 20, 2016 (GLOBE NEWSWIRE) -- Annual bonuses for U.S. corporate executives in 2016 will be decidedly mixed, a reflection of the wide variation in industry-by-industry corporate performance this year, according to a poll by Willis Towers Watson (NASDAQ: WLTW ), a leading global advisory, broking and solutions company. The poll also found that while many companies believe the mandatory say-on-pay shareholder vote has been positive, more than a quarter of respondents believe the rule may no longer be necessary.  

More than a third of the companies polled (36%) expect to pay annual bonuses for 2016 performance that exceed 110% of target, while roughly the same number (35%) anticipate paying bonuses at 90% of target or below. The balance (29%) expect to pay annual incentives close to target. The poll of 260 corporate executives and compensation professionals was conducted December 8 during the Willis Towers Watson national webcast on the 2017 proxy season.

“We were somewhat surprised that so many companies expect to pay bonuses well above target for 2016 performance, given the relatively tepid growth in revenue and earnings in many industries this year,” said Andrew Goldstein, leader of the Executive Compensation practice in North America, Willis Towers Watson. “While the stock market, and thus shareholder returns, surged late in the year, the underlying corporate financial performance for much of 2016 was mediocre overall, which might have suggested a continuation of the downward trend in bonus payouts that we saw in 2015. But without question, third quarter financial results improved, so the strength of the fourth quarter could alter the balance.”

Overall, nearly half of the respondents (47%) said the impact of mandatory say-on-pay voting has been very or generally positive. Interestingly, more than a quarter (29%) said while the Dodd-Frank requirement has been generally positive, it’s probably no longer necessary. Only one in 10 said the voting has had a negative impact, and just 4% favor repealing it.

“It will be interesting to see how corporate America responds if the Trump administration moves to repeal Dodd-Frank outright,” said Goldstein. “Our findings suggest that most companies are fairly comfortable with say on pay, in part because institutional investors and proxy advisors would be more likely to oppose the reelection of compensation committee members or other directors in the absence of the say-on-pay vote. While the fate of other Dodd-Frank rules, such as the CEO pay ratio disclosure, is clearly up in the air, it’s quite possible that many companies would continue conducting say-on-pay votes voluntarily even if the Dodd-Frank requirement is repealed.”   

The poll also found the vast majority of respondents (83%) currently have some type of clawback policy in place that covers fraud, misconduct or financial restatements, or a combination of those. While most of these companies aren’t likely to expand their policy, roughly one in 10 respondents say they’re likely to consider expanding their clawback policy to cover situations that result in significant financial or reputational harm.

“Recent company situations have forced many boards of directors to consider ‘what if that happened here’ scenarios. We strongly recommend companies carefully review their clawback policies to ensure they’re broad enough to permit a clawback for circumstances that result in significant financial or reputational harm to the company. Boards need to consider how shareholders might react if they weren’t empowered to use their discretion to hold back or recoup incentive compensation in these situations,” said Goldstein.

About Willis Towers Watson Willis Towers Watson (NASDAQ: WLTW ) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 39,000 employees in more than 120 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.

Media contact Ed Emerman: +1 609 275 5162 eemerman@eaglepr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 550

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 305

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 36

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 595

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

X-Bow Systems Appoints Experienced COO to Boost Growth

Updated Category News Views 202

X-Bow Systems Inc. scored a major win back in early 2024, tapping Mike Bender as the new Chief Operating Officer. Now, you gotta know—this guy's got over thirty years under his belt in aerospace and defense, so he's not just some suit walking in off the street. New COO in Charge: What’s His Game Plan? Bender's gonna oversee the company's factories and supply chain...

Continue Reading
UroGen Pharma Q3 Financial Overview: Anticipating UGN-102 Launch

Updated Category News Views 108

UroGen Pharma's Third Quarter Financial Report UroGen Pharma Ltd. (NASDAQ: URGN), a company focused on developing innovative therapies for urothelial and specialty cancers, has recently published their financial outcomes for the third quarter of 2024, along with key updates on their operations. This report is particularly pivotal, as it sets the stage for UroGen's future...

Continue Reading
Understanding Recent Options Trends for Chevron: Key Insights

Updated Category News Views 87

Decoding Chevron's Recent Options Activity Investors are closely watching Chevron as recent options activity reveals significant trends among traders. An analysis of the latest trades indicates a predominantly bearish sentiment, with a total of 16 unusual trades being noted. This movement offers a compelling glimpse into investor expectations and potential future price...

Continue Reading
New Research Highlights Life-Extending Benefits of Quitting Smoking for Cancer Patients

Updated Category News Views 160

Research Highlights Impact of Quitting Smoking on Cancer Survival Recent studies indicate that individuals diagnosed with stage III or IV cancer who stop smoking can enjoy nearly one additional year of life compared to those who continue the habit. This finding underscores the essential role that smoking cessation support plays in cancer care. Significant Findings from...

Continue Reading
De La Rue plc Strategic Dealings Unfolding in the Market

Updated Category News Views 189

Overview of Dealings in De La Rue plc As the market evolves, companies like De La Rue plc are continuously involved in dynamic trading activities that provide essential insights into their operations. These dealings are not only a reflection of market conditions but also signify a company’s strategy to navigate the complexities of financial frameworks. Key Details of...

Continue Reading